The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
THE IL-4 RECEPTOR: Signaling Mechanisms and Biologic Functions
Abstract
Interleukin-4 is a multifunctional cytokine that plays a critical role in the regulation of immune responses. Its effects depend upon binding to and signaling through a receptor complex consisting of the IL-4R alpha chain and the common gamma chain (gamma c), resulting in a series of phosphorylation events mediated by receptor-associated kinases. In turn, these cause the recruitment of mediators of cell growth, of resistance to apoptosis, and of gene activation and differentiation. Here we describe our current understanding of the organization of the IL-4 receptor, of the signaling pathways that are induced as a result of receptor occupancy, and of the various mechanisms through which receptor function is modulated. We particularly emphasize the modular nature of the receptor and the specialization of different receptor regions for distinct functions, most notably the independent regulation of cell growth and gene activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“previous studies have shown that phosphorylation of STAT6 is a key step downstream in the IL-4 cascade that leads to Arg1 expression (49–51).”
From Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [50]
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
SH2 domains recognize specific phosphopeptide sequences
Songyang, Z. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,620
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M. H., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,237
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Proteins regulating Ras and its relatives
Boguski, M. S., & McCormick, F. P. (1993) · Nature · doi:10.1038/366643a0 · Cited by 1,905
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,665
Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,629
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Cited by
Sorted by citations
Items 601–700 of 1,002
Vella, V., Mineo, R., Frasca, F., Mazzon, E., Pandini, G., Vigneri, R., & Belfiore, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031639 · Cited by 40
Suppressor of Cytokine Signaling 3 Sensitizes Anaplastic Thyroid Cancer to Standard Chemotherapy
Francipane, M. G., Eterno, V., Spina, V., Bini, M., Scerrino, G., Buscemi, G., Gulotta, G., Todaro, M., Dieli, F., Maria, R. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0994 · Cited by 40
Wang, H. Y., Shelburne, C. P., Zamorano, J., Kelly, A. E., Ryan, J. J., & Keegan, A. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4385 · Cited by 40
“Binding of IL-4 to either receptor complex results in the tyrosine phosphorylation of several signal transduction molecules including the insulin receptor substrates (IRS) -1 and -2, and a member of the STAT family, STAT6 (14).”
BackgroundDames, P., Bergann, T., Fromm, A., Bücker, R., Barmeyer, C., Krug, S. M., Fromm, M., & Schulzke, J. (2015) · The Journal of Physiology · doi:10.1113/jp271156 · Cited by 39
“Additionally, STAT-independent activation of the PI3K signalling cascade has been described (Nelms et al. 1999), but in our study did not appear to have a role for the inhibition of JNa, as indicated by the absence of an effect of Ly294002.”
BackgroundRole of IL-4 Gene Polymorphisms in HBV-Related Hepatocellular Carcinoma in a Chinese Population
Yu, L., Wu, Z., Peng, Q., Ma, L., Zhang, X., Zhao, J., Qin, X. Y., & Li, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110061 · Cited by 39
Dedicator of Cytokinesis 2 in Cell Signaling Regulation and Disease Development
Guo, X., & Chen, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25512 · Cited by 40
Molecular and Cellular Responses to Interleukin-4 Treatment in a Rat Model of Transient Ischemia
Lively, S. S., Hutchings, S., & Schlichter, L. C. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw081 · Cited by 40
“IL-4 injection increased the anti-inflammatory profile at 1 day (elevated CD163, ARG1, CCL22, PPARc), and, importantly, some effects were long lasting.”
BackgroundInfluentialMAP kinase activation by interleukin-9 in lymphoid and mast cell lines
Demoulin, J., Louahed, J., Dumoutier, L., Stevens, M., & Renauld, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206253 · Cited by 39
“Besides these negative results, phosphorylation of SHC in response to IL-4 has been reported in two hematopoietic cell lines: 32D and WEHI-231, in line with our results (Zamorano and Keegan, 1998; Nelms et al., 1999; Gingras et al., 2000).”
BackgroundResultInfluentialIL‐4 blocks M‐CSF‐dependent macrophage proliferation by inducing p21Waf1 in a STAT6‐dependent way
Arpa, L., Valledor, A. F., Lloberas, J., & Celada, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200838283 · Cited by 39
Carey, G. B., Semenova, E. A., Qi, X., & Keegan, A. D. (2007) · Cell Research · doi:10.1038/sj.cr.2007.90 · Cited by 39
Interleukin-13 (IL-13) Pathway
Kelly-Welch, A. E., Hanson, E. M., & Keegan, A. D. (2005) · Science s STKE · doi:10.1126/stke.2932005cm8 · Cited by 39
Fujii-Maeda, S., Kajiwara, K., Ikizawa, K., Shinazawa, M., Yu, B., Koga, T., Furue, M., & Yanagihara, Y. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22103.x · Cited by 39
“No tyrosine phosphorylation was induced by any cytokine stimulation (data not shown)”
BackgroundWesterberg, L. S., Wallin, R. P. A., Greicius, G., Ljunggren, H., & Gronowicz, E. S. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01668.x · Cited by 39
Tumor Rejection by Modulation of Tumor Stromal Fibroblasts
Schüler, T., Körnig, S., & Blankenstein, T. J. F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030849 · Cited by 39
“Given that (a) IL4Rs are expressed on most, if not all, cell types (16), and (b) that IL-4 mediates its antitumor effect locally rather than systemically (1), we asked whether non-BM–derived stromal cells contribute to IL-4–mediated tumor rejection.”
BackgroundThe Role of Inflammatory Mediators in the Development of Gastrointestinal Motility Disorders
Docsa, T., Sipos, Á., Cox, C. S., & Uray, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136917 · Cited by 40
“demonstrated IL-4Rα mRNA expression in dispersed longitudinal smooth muscle cells from the jejunum of C57Bl/6 mice and NIH Swiss mice through RT-PCR [42,43].”
BackgroundMethodInfluentialExploring the Role of Hormones and Cytokines in Osteoporosis Development
Umur, E., Bulut, S. B., Yiğit, P., Bayrak, E., Arkan, Y., Arslan, F., Baysoy, E., Kaleli‐Can, G., & Ayan, B. (2024) · Biomedicines · doi:10.3390/biomedicines12081830 · Cited by 42
“It regulates immune responses and is recognized as a potent osteoclastogenesis inhibitor, directly and indirectly affecting osteoclast formation and function [214].”
BackgroundRegulation of Fcγ receptors and immunoglobulin G-mediated phagocytosis in mouse microglia
Quan, Y., Möller, T., & Weinstein, J. R. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.013 · Cited by 38
“IFN-γ and IL-4/IL-13, are pleiotropic modulators of macrophage activation and can each induce distinctive programs of altered gene expression after engagement of their specific receptors[1,24].”
BackgroundIto, T., Suzuki, S., Kanaji, S., Shiraishi, H., Ohta, S., Arima, K., Tanaka, G., Tamada, T., Honjo, E., García, K. C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007286 · Cited by 38
Li, B. H., Xu, S. B., Li, F., Zou, X. G., Saimaiti, A., Simayi, D., Wang, Y. H., Zhang, Y., Yuan, J., & Zhang, W. J. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.005 · Cited by 38
Movahedi, M., Amirzargar, A. A., Kalmarzi, R. N., Hirbod‐Mobarakeh, A., Farhadi, E., Tavakol, M., Behniafard, N., Ansaripour, B., Moradi, B., Zare, A., et al. (2013) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2013.05.002 · Cited by 38
Wheeler, J. C., Vanoni, S., Zeng, C., Waggoner, L., Yang, Y., Wu, D. X.-Y., Uddin, J., Karns, R. A., Kottyan, L. C., Mukkada, V. A., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.070 · Cited by 40
Ertl, H. C. J. (2023) · Drugs · doi:10.1007/s40265-023-01836-1 · Cited by 41
“Cytokines such as interleukin (IL)-4 or IL-21 contribute to B-cell activation by signaling through Janus kinases (JAK)1, 3 and tyrosine kinase (TYK)1, leading to activation of the signal transducer and activator of transcription (STAT)6 or STAT1, three pathways, respectively [71, 72].”
BackgroundBao, B., Thakur, A. B., Li, Y., Ahmad, A., Azmi, A. S., Banerjee, S., Kong, D., Ali, S. S., Lum, L. G., & Sarkar, F. H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.11.002 · Cited by 38
“of IFN-γ from Th1 cells, resulting in the switch of from Th1 to Th2 polarization [27].”
BackgroundNakamura, E., Megumi, Y., Kobayashi, T., Kamoto, T., Ishitoya, S., Terachi, T., Tachibana, M., Matsushiro, H., Habuchi, T., Kakehi, Y., et al. (2002) · PubMed · Cited by 38
IL-4 Potentiates Activated T Cell Apoptosis Via an IL-2-Dependent Mechanism
Zhang, J., Bárdos, T., Shao, Q., Tschopp, J., Mikecz, K., Glant, T. T., & Finnegan, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3495 · Cited by 38
“Because IL-4-dependent gene activation involves activation of STAT-6 (1, 65), it was crucial to determine whether the impairment in AICD in IL-4 / T cells was dependent upon the JAK/ STAT-6 signaling pathway.”
BackgroundVadevoo, S. M. P., Kim, J., Gunassekaran, G. R., Jung, H.-K., Chi, L., Kim, D. E., Lee, S., Im, S., & Lee, B.-H. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0339 · Cited by 37
“Type I is composed of IL4Ra and common g-chain and is expressed on the surface of cells of hematopoietic stem cell origin (16, 17).”
BackgroundWebb, D. C., Mahalingam, S., Cai, Y., Matthaei, K. I., Donaldson, D. D., & Foster, P. S. (2003) · European Journal of Immunology · doi:10.1002/eji.200324178 · Cited by 37
Characterization of RNA helicase A as component of STAT6-dependent enhanceosome
Välineva, T., Yang, J., & Silvennoinen, O. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl539 · Cited by 37
“STAT6 is a signal transducer and transcription activator that is activated by IL-4 induced tyrosine phosphorylation and mediates most of the IL-4- and IL-13-induced gene responses (6).”
BackgroundIL-4 Biology: Impact on Normal and Leukemic CLL B Cells
Kay, N. E., & Pittner, B. T. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000068007 · Cited by 37
“An additional component that mediates effects of IL-4R generated signals is a member of the signal transducer and activator of transcription (STAT) factors, STAT6 [17,23].”
BackgroundPesu, M., Aittomäki, S., Takaluoma, K., Lagerstedt, A., & Silvennoinen, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201427200 · Cited by 37
Karo‐Atar, D., Itan, M., Pasmanik‐Chor, M., & Munitz, A. (2014) · Journal of Asthma · doi:10.3109/02770903.2014.988222 · Cited by 36
“IL-13 induces the expression of miR-511 but not miR-449a IL-4 and IL-13 share the requirement for IL-4Ra and the phosphorylation and translocation of STAT-6 for their optimal signaling [10].”
BackgroundInfluentialMüller, U., Piehler, D., Stenzel, W., Köhler, G., Frey, O., Held, J., Grahnert, A., Richter, T., Eschke, M., Kamradt, T., et al. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.9 · Cited by 36
Cho, S. H., Oh, S. Y., Zhu, Z., Lee, J., & Lane, A. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035114 · Cited by 36
“Once phosphorylated and activated, SHP-1 binds to and dephosphorylates its target molecules to terminate signaling [12].”
BackgroundBurt, B. M., Bader, A., Winter, D. G., Rodig, S. J., Bueno, R., & Sugarbaker, D. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1808 · Cited by 36
“We then cultured MPM tumor cells in the presence of IL-4 to determine whether IL-4 caused activation of STAT-6 signaling.”
InfluentialM2‐like macrophages serve as a niche for adipocyte progenitors in adipose tissue
Nawaz, A., & Tobe, K. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13114 · Cited by 36
Regulation of the humoral type 2 immune response against allergens and helminths
Haase, P., & Voehringer, D. (2020) · European Journal of Immunology · doi:10.1002/eji.202048864 · Cited by 38
Hernandez, J. D., Li, T., Rau, C. M., LeSuer, W. E., Wang, P., Coletta, D. K., Madura, J. A., Jacobsen, E. A., & Filippis, E. D. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00801-w · Cited by 36
The mechanism of the cytotoxic effect of Panax notoginseng extracts on prostate cancer cells
Hawthorne, B., Lund, K., Freggiaro, S., Kaga, R., & Meng, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112887 · Cited by 36
Kienzle, N., Baz, A., & Kelso, A. (2004) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2004.01210.x · Cited by 36
“In fact, a major complicating factor for studying the effects of IL-4 on CD8 T-cell differentiation is the parallel impact of IL-4 at two levels of CD8 T-cell activation: at the direct level, IL-4 binds to the IL-4 receptor and induces IL-4-specific signalling cascades in the T cell; these signals subsequently cause t…”
BackgroundNabeshima, Y., Hiragun, T., Morita, E., Mihara, S., Kameyoshi, Y., & Hide, M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.104 · Cited by 36
“The IL-4 receptor consists of IL-4 receptor a and gamma common chain (cc), and the latter can be replaced by IL-13 receptor a (type II IL-4 receptor) [6].”
BackgroundT cell-Associated Cytokines in the Pathogenesis of Sjögren’s Syndrome
Jin, J., & Yu, Q. (2011) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.s1-009 · Cited by 36
“IL-4 amplifies Th2 differentiation, mediates asthma and allergy and provides critical stimulating signals for the growth and function of activated B cells [63,64].”
BackgroundTumor cells secreting IL-13 but not IL-13R 2 fusion protein have reduced tumorigenicity in vivo
Ma, H.-L. (2004) · International Immunology · doi:10.1093/intimm/dxh105 · Cited by 39
Redundant and unique regulation of activated mouse B lymphocytes by IL-4 and IL-21
Jin, H., & Malek, T. R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206096 · Cited by 36
“IgG1 is a dominant IgG isotype in secondary antibody responses, and class-switching to this isotype depends on IL-4 [17].”
BackgroundTabata, H., Matsuoka, T., Endo, F., Nishimura, Y., & Matsushita, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002089200 · Cited by 36
Bouton, L. A., Ramírez, C. D., Bailey, D. P., Yeatman, C. F., Yue, J., Wright, H. V., Domen, J., Rosato, R. R., Grant, S., Fischer‐Stenger, K., et al. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.09.002 · Cited by 36
“It induces Th2 development, IgE production (reviewed in [13]), and acts as a mast cell co-mitogen [14].”
BackgroundIL-4 Signaling, Gene Transcription Regulation, and the Control of Effector T Cells
Boothby, M. R., Mora, A. L., Aronica, M. A., Youn, J., Sheller, J. R., Goenka, S., & Stephenson, L. M. (2001) · Immunologic Research · doi:10.1385/ir:23:2-3:179 · Cited by 36
Chen, J., Ni, G., & Liu, X. S. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.03.003 · Cited by 35
Interleukin-4 Induces Senescence in Human Renal Carcinoma Cell Lines through STAT6 and p38 MAPK
Kim, H. D., Yu, S.-J., Kim, H. S., Kim, Y.-J., Choe, J. M., Park, Y. G., Kim, J., & Sohn, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499053 · Cited by 37
“IL-4 Induces Strong and Persistent STAT6 Activation in Caki-1 Cells—The heterodimerization of IL-4R subunits by IL-4 is known to activate JAK kinases, which then stimulate at least two different signaling pathways involving either STAT6 or insulin receptor substrate-1/2 (6, 37).”
BackgroundGonnord, P., Angermann, B., Sadtler, K., Gombos, E., Chappert, P., Meier‐Schellersheim, M., & Varma, R. (2018) · Science Signaling · doi:10.1126/scisignal.aal1253 · Cited by 35
Pignarre, A., Chatonnet, F., Caron, G., Haas, M., Desmots, F., & Fest, T. (2020) · Blood · doi:10.1182/blood.2020005083 · Cited by 36
Single Cell Analysis of Ligand Binding and Complex Formation of Interleukin-4 Receptor Subunits
Weidemann, T., Worch, R., Kurgonaite, K., Hintersteiner, M., Bökel, C., & Schwille, P. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.10.014 · Cited by 35
“Whereas phosphorylation of Y575, Y603, Y631 (mature numbering) regulates differentiation via STAT6, IL-4 also acts as a growth factor for lymphoid cells via Y497 and IRS-1 (16).”
BackgroundGene expression profiling of non‐alcoholic steatohepatitis using gene set enrichment analysis
Yoneda, M., Endo, H., Mawatari, H., Nozaki, Y., Fujita, K., Akiyama, T., Higurashi, T., Uchiyama, T., Yoneda, K., Takahashi, H., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00399.x · Cited by 35
Sasaki, K., Pardee, A. D., Qu, Y., Zhao, X., Ueda, R., Kohanbash, G., Bailey, L. M., Okada, H., Muthuswamy, R., Kaliński, P., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181acec1e · Cited by 35
“Stat6 is an important down-stream component of the IL-4R-mediated signaling pathway.(16,17) Therefore, we next determined whether ablation of IL-4R signaling in STAT6 ( / ) mice would yield T-cells refractory to IL-4-induced silencing of VLA-4 and VLA-6 expression.”
BackgroundNjoku, D. B. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003601979 · Cited by 35
“Intracellular signaling resulting in upregulation of these genes is initiated by IL-4 engagement of the IL-4 receptor, which is formed by the two side chains IL-4Ra as well as the IL-2Rg chain (Figure 2) [28].”
Chromatin remodeling at the Th2 cytokine gene loci in human type 2 helper T cells
Kaneko, T., Hosokawa, H., Yamashita, M., Wang, C., Hasegawa, A., Kimura, M. Y., Kitajiama, M., Kimura, F., Miyazaki, M., & Nakayama, T. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.11.004 · Cited by 35
Ahn, J. S., & Agrawal, B. (2005) · International Immunology · doi:10.1093/intimm/dxh312 · Cited by 35
Genetic Signatures of Asthma Exacerbation
Park, H., & Tantisira, K. G. (2017) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2017.9.3.191 · Cited by 35
“Both IL13 and IL-4 signals act via the common IL-4 receptor alpha (IL4Rα).(16) In 2 well-characterized cohorts of severe asthmatics, 2 non-synonymous coding SNPs (rs1805011 [E375A] and rs1801275 [Q551R]) were associated with AE requiring an intensive care unit stay or intubation in addition to lower lung function and…”
BackgroundMüller, U., Stenzel, W., Köhler, G., Polte, T., Blessing, M., Mann, A., Piehler, D., Brombacher, F., & Alber, G. (2008) · The Journal of Infectious Diseases · doi:10.1086/593068 · Cited by 35
Polymorphisms in the IL4 and IL4RA genes in Colombian patients with rheumatoid arthritis.
Moreno, O. M., González, C. I., Saaibi, D. L., Otero, W., Badillo, R., Martin, J. J., & Ramírez, G. (2007) · PubMed · Cited by 35
Bottini, N., Borgiani, P., Otsu, A., Saccucci, P., Stefanini, L., Greco, E., Fontana, L., Hopkin, J. M., Mao, X. ‐., & Shirakawa, T. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.610408.x · Cited by 35
“The alpha chain of the IL-4 receptor (IL-4RA) constitutes part of receptors for both IL-4 and IL13, which are important cytokines in mediating the isotype switching to IgE, and finally, in the pathogenesis of atopy and allergic diseases (1).”
BackgroundLieberson, R., Mowen, K. A., McBride, K. D., Leautaud, V., Zhang, X., Suh, W., Wu, L., & Glimcher, L. H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.89 · Cited by 35
Constrained mixture estimation for analysis and robust classification of clinical time series
Costa, I. G., Schönhuth, A., Hafemeister, C., & Schliep, A. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp222 · Cited by 35
Schulz-Kuhnt, A., Greif, V., Hildner, K. M., Knipfer, L., Döbrönti, M., Zirlik, S., Fuchs, F. S., Atreya, R. N., Zundler, S., López-Posadas, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00691 · Cited by 34
“Membranes were incubated overnight at 4◦C with the following primary antibodies: Col VI (Abcam), Col I (Cell Signaling Technology), phospho-STAT3 (Cell Signaling Technology), STAT3 (Cell Signaling Technology), phosphoSTAT6 (Cell Signaling Technology) and STAT6 (Cell Signaling Technology). β-Actin (Cell Signaling Techn…”
BackgroundInfluentialNovel Biological Therapies for Severe Asthma Endotypes
Pelaia, C., Pelaia, G., Crimi, C., Maglio, A., Stanziola, A. A., Calabrese, C., Terracciano, R., Longhini, F., & Vatrella, A. (2022) · Biomedicines · doi:10.3390/biomedicines10051064 · Cited by 35
Conjunctival Goblet Cell Function
García-Posadas, L., Contreras‐Ruiz, L., Soriano-Romaní, L., Dartt, D. A., & Diebold, Y. (2015) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0000000000000158 · Cited by 34
“Interleukin 4 is necessary for Th2 lymphocyte differentiation and it is later secreted by these Th2 cells.(71) This pleiotropic cytokine binds to IL-4 receptors to activate signal trans-”
BackgroundGene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis
Hosoya, K., Satoh, T., Yamamoto, Y., Saeki, K., Igawa, K., Okano, M., Moriya, T., Imamura, O., Nemoto, Y., & Yokozeki, H. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02440.x · Cited by 34
“Binding of IL-4 or IL-13 induces phosphorylation of STAT6 via JAK1 and JAK3 kinases, resulting in the homodimer formation and translocation to the nucleus (1).”
BackgroundJin, Y., Yan, E., Li, X., Fan, Y., Zhao, Y., Liu, Z., & Liu, W. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00848.x · Cited by 34
Néron, S., Suck, G., Ma, X., Sakac, D., Roy, A., Katsman, Y., Dussault, N., Racine, C., & Branch, D. R. (2006) · International Immunology · doi:10.1093/intimm/dxh377 · Cited by 34
Kinetics of GATA‐3 gene expression in early polarizing and committed human T cells
Lantelme, E., Mantovani, S., Palermo, B., Campanelli, R., Sallusto, F., & Giachino, C. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01168.x · Cited by 34
Guillot, C., Coathalem, H., Chetritt, J. J., David, A., Lowenstein, P. R., Gilbert, E., Tesson, L., van Rooijen, N., Cuturi, M. C., Soulillou, J., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5225 · Cited by 34
“The IL-4R a intracellular segment contains distinct domains responsible for cell proliferation, regulation of apoptosis, and gene expression (39).”
BackgroundBeum, P. V., Basma, H., Bastola, D. R., & Cheng, P. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00370.2003 · Cited by 34
Narożna, B., Hoffmann, A., Sobkowiak, P., Schöneich, N., Bręborowicz, A., & Szczepankiewicz, A. (2015) · Advances in Medical Sciences · doi:10.1016/j.advms.2015.07.003 · Cited by 33
Heller, N. M., Gwinn, W. M., Donnelly, R. P., Constant, S. L., & Keegan, A. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039673 · Cited by 33
“These results are consistent with equilibrium binding studies on primary cells showing that the numbers of IL-4 and IL-13 binding sites range from 50–5000 per cell [24].”
ResultOvsyannikova, I. G., Haralambieva, I. H., Kennedy, R. B., Pankratz, V. S., Vierkant, R. A., Jacobson, R. M., & Poland, G. A. (2012) · Gene · doi:10.1016/j.gene.2012.08.021 · Cited by 33
“…between the IL4 gene haplotype, which includes the known functional SNP rs2243250, and a decreased risk for fever might be the influence of a Th2 type-modulated increase in IL-4 production and concomitant suppression of IFN-γ production and Th1 responses (Nelms et al., 1999; Stanley et al., 2007).”
Cell-Autonomous CCL5 Transcription by Memory CD8 T Cells Is Regulated by IL-4
Marçais, A., Coupet, C., Walzer, T., Tomkowiak, M., Ghittoni, R., & Marvel, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4451 · Cited by 33
“STAT6 is the main transcription factor activated by IL-4 (23, 31, 32), Indeed, when IL-4 binds to its receptor it induces the activation of JAK 1 and 3 that, in turn, phosphorylate cytoplasmic STAT6, which then undergoes dimerization and is translocated to the nucleus where it can either activate (23) or repress gene…”
BackgroundChaudhari, A. A., Kim, W. H., & Lillehoj, H. S. (2018) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2018.10.011 · Cited by 33
Liu, Q., Gao, Y., Zhang, B., Sun, F., Yang, Q., Liu, Y., Wu, J., Chen, K., Weng, X., Zhang, W., et al. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.08.019 · Cited by 34
Aguilera, J., Han, X., Cao, S., Balmes, J. R., Lurmann, F. W., Tyner, T. R., Lutzker, L., Noth, E. M., Hammond, S. K., Sampath, V., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01254-2 · Cited by 34
“IL4 aids in the polarization of antigen-stimulated naïve Th cells into Th2 effector cells and propagates Th2 responses, while IL10 downregulates Th1 cells [19, 29].”
BackgroundNilsson, M., Rhedin, M., Hendrickx, R., Berglund, S., Piras, A., Blomgran, P., Cavallin, A., Collins, M., Dahl, G., Dekkak, B., et al. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s354291 · Cited by 33
“In the context of asthma, IL-4 can signal through two alternative receptor complexes: an IL-4 receptor α (IL-4Rα)/IL-2 common γ-chain receptor complex, which recruits JAK1 and JAK3, or an IL-4Rα/IL-13Rα receptor complex, which recruits JAK1 and JAK2 or TYK2.(19,21) IL-13 is also able to signal through the IL-4Rα/IL-13…”
BackgroundPerona‐Wright, G., Mohrs, K., Mayer, K. D., & Mohrs, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902408 · Cited by 31
“IL-4 signals through either the type I IL-4 receptor, which com- prises IL-4Ra and the common g (gc) chain, or the type II IL-4 receptor in which IL-4Ra is paired with IL-13Ra1 (12).”
BackgroundInfluentialHattori, M., Mizuguchi, H., Baba, Y., Ono, S., Nakano, T., Zhang, Q., Sasaki, Y., Kobayashi, M., Kitamura, Y., Takeda, N., et al. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2012.12.030 · Cited by 33
Cytokine gene transfer for cancer therapy
Podhajcer, O. L., Lopez, M. V., & Mazzolini, G. D. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.014 · Cited by 32
“Among other interesting cytokines evaluated in preclinical trials, IL-4 is a paradigmatic Th2 cytokine as mice lacking either IL-4 or IL-4 receptors fail to develop Th2 cells [25].”
BackgroundBorn, W. K., Huang, Y., Reinhardt, R. L., Huang, H., Sun, D., & O’Brien, R. L. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.01.002 · Cited by 35
Frejo, L., Cara, F. E., Flook, M., Robles-Bolívar, P., Escalera‐Balsera, A., Montilla-Ibáñez, M. A., Domínguez‐Durán, E., Martinez-Martinez, M., Perez‐Carpena, P., & Lopez-Escamez, J. A. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110413 · Cited by 38
Interleukin‐4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus
Mahmoudi, M., Tahghighi, F., Ziaee, V., Harsini, S., Rezaei, A., Soltani, S., Sadr, M., Moradinejad, M.-H., Aghighi, Y., & Rezaei, N. (2014) · International Journal of Immunogenetics · doi:10.1111/iji.12152 · Cited by 32
“IL-4 has been identified as an important actor in regulating the differentiation of antigen-stimulated naive T cells to develop into T helper 2 (Th2), which is capable of secreting cytokines such as IL-4, IL-5, IL-6 and IL-10, and contributes towards humoral immune responses (Mosmann & Coffman, 1989; Nelms et al., 199…”
BackgroundDisruption of the γc cytokine network in T cells during HIV infection
Sirskyj, D., Thèze, J., Kumar, A., & Kryworuchko, M. (2008) · Cytokine · doi:10.1016/j.cyto.2008.03.001 · Cited by 32
RETRACTED: Interleukin‐4 activates androgen receptor through CBP/p300
Lee, S. O., Chun, J. Y., Nadiminty, N., Lou, W., Feng, S., & Gao, A. C. (2008) · The Prostate · doi:10.1002/pros.20865 · Cited by 33
“In addition to its effect on immune cells, IL-4 has a variety of other functions including effects on hematopoietic tissues, tissue adhesion and inflammation (2).”
BackgroundRetractedDasgupta, P., Chapoval, S. P., Smith, E., & Keegan, A. D. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-60 · Cited by 32
“Apart from TH2 cells, IL-4 and IL-13 are also secreted by natural killer (NK) T cells, basophils, mast cells, macrophages and activated eosinophils (reviewed in [12]).”
BackgroundMin, S., Zhu, M., Mao, X., Li, W., Wei, T., Mei, M., Zhang, Y., Wu, L., Yu, G., & Cong, X. (2021) · Arthritis & Rheumatology · doi:10.1002/art.42052 · Cited by 33
“The Th2-derived cytokine IL-4 is pleiotropic and may be involved in differentiation, proliferation, or apoptosis depending on the cell type (39,40).”
BackgroundOhta, Y., Hayashi, M., Kanemaru, T., Abe, K., Ito, Y., & Oike, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4191 · Cited by 32
“It is known that the IL-4R chain binds IL-4 and dimerizes with IL-13R 1 to form a type II IL-4R in nonhematopoietic cells (27).”
BackgroundInterleukin 4, interleukin 4 receptor‐α and interleukin 10 gene polymorphisms in Chagas disease
Flórez-Vargas, O., Martin, J. J., & González, C. I. (2011) · Parasite Immunology · doi:10.1111/j.1365-3024.2011.01314.x · Cited by 32
Natural Tregs and autoimmunity
Cava, A. L. (2009) · Frontiers in bioscience · doi:10.2741/3247 · Cited by 31
Toxin-Based Targeted Therapy for Malignant Brain Tumors
Chandramohan, V., Sampson, J. H., Pastan, I. H., & Bigner, D. D. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/480429 · Cited by 32
“IL-4 regulates the differentiation of antigen-stimulated naive T cells and the specificity of immunoglobulin class switching by B cells [62].”
BackgroundInfluentialFeuser, K., Feilhauer, K., Staib, L., Bischoff, S. C., & Lorentz, A. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.10.010 · Cited by 32
A New Mechanism for Inhalational Priming: IL-4 Bypasses Innate Immune Signals
Dittrich, A., Chen, H., Xu, L., Ranney, P., Connolly, S., Yarovinsky, T. O., & Bottomly, H. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7307 · Cited by 32
“IL-4 has been known for decades to be a cytokine with a pivotal role in the development of Th2-polarized T cells (11, 12), and hence Th2-polarized immune responses (13–17), resulting from its pleiotropic effects, which encompass hematopoietic and nonhematopoietic cells (18).”
BackgroundInterleukin-4 in patients with prostate cancer.
Ueda, T., Sadar, M. D., Suzuki, H., Akakura, K., Sakamoto, S., Shimbo, M., Suyama, T., Imamoto, T., Komiya, A., Naya, Y., et al. (2005) · PubMed · Cited by 32
Interleukin-4: A multifunctional cytokine
Zamorano, J. L., Perez-G, M., & la Investigación, U. D. R. D. I. C. P. (2003) · Cited by 32
Kianoush, F., Nematollahi, M., Waterfield, J. D., & Brunette, D. M. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36107 · Cited by 32
Iribarren, P., Chen, K., Hu, J., Zhang, X., Gong, W., & Wang, J. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6100 · Cited by 32
“Furthermore, our study revealed that up-regulation of the phosphatase PP2A, in a manner independent of Stat6, may play an essential role in IL4-mediated attenuation of the TNF- signaling cascade in microglial cells and the resultant expression mFPR2, the mouse homolog of human FPRL1, a functional receptor for the AD-a…”
BackgroundInfluentialIL-4 Induces the Proteolytic Processing of Mast Cell STAT6
Sherman, M. A., Powell, D. R., & Brown, M. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3811 · Cited by 34
Metadata
- Authors
- Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Nelms, Keats
- Paul, William E.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 1999-04
- Volume
- 17
- Issue
- 1
- Pages
- 701-738
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2144120552
- Cited by
- 1,545
- References
- 190
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 52 · 2023: 36 · 2022: 54 · 2021: 43 · 2020: 50 · 2019: 44 · 2018: 54 · 2017: 49 · 2016: 52 · 2015: 56 · 2014: 72 · 2013: 52 · 2012: 55
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- IL-4, IL-4 receptor, common gamma chain, receptor signaling, receptor phosphorylation, cell growth regulation, apoptosis resistance, gene activation, T cell differentiation, cytokine signaling
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Phosphoproteins, Signal Transduction, Trans-Activators, Interleukin-4, Protein Tyrosine Phosphatases, Calcium-Calmodulin-Dependent Protein Kinases, Mice, Knockout, Receptors, Interleukin-4, Mitogen-Activated Protein Kinases, Intracellular Signaling Peptides and Proteins, JNK Mitogen-Activated Protein Kinases, STAT6 Transcription Factor, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review